TPM3-ALK and TPM4-ALK Oncogenes in Inflammatory Myofibroblastic Tumors-Reference-Cited by-同舟云学术

TPM3-ALK and TPM4-ALK Oncogenes in Inflammatory Myofibroblastic Tumors

Published:2000-08 Issue:2 Volume:157 Page:377-384
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Lawrence Brandon,Perez-Atayde Antonio,Hibbard Michele K.,Rubin Brian P.,Dal Cin Paola,Pinkus Jack L.,Pinkus Geraldine S.,Xiao Sheng,Yi Eunhee S.,Fletcher Christopher D.M.,Fletcher Jonathan A.

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference40 articles.

1. Inflammatory fibrosarcoma of the mesentery and retroperitoneum. A tumor closely simulating inflammatory pseudotumor;Meis;Am J Surg Pathol,1991

2. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases;Coffin;Am J Surg Pathol,1995

3. Inflammatory myofibroblastic tumor, inflammatory fibrosarcoma, and related lesions: an historical review with differential diagnostic considerations;Coffin;Semin Diagn Pathol,1998

4. Inflammatory myofibroblastic tumor or inflammatory fibrosarcoma?;Hasegawa;Pathol Case Review,1998

5. Omental-mesenteric inflammatory pseudotumor. Cytogenetic demonstration of genetic changes and monoclonality in one tumor;Treissman;Cancer,1994

Cited by 601 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of tropomyosin 3 in the development of malignant tumors;Heliyon;2024-08

2. ALK-Rearranged Renal Cell Carcinoma: A Multi-Institutional Study of 9 Cases With Expanding the Morphologic and Molecular Genetic Spectrum;Modern Pathology;2024-08

3. Treatment of intracranial inflammatory myofibroblastic tumor with PD-L1 inhibitor and novel oncolytic adenovirus Ad-TD-nsIL12: a case report and literature review;Frontiers in Immunology;2024-07-24

4. ALK-rearranged mesenchymal neoplasms: a clinicopathological and molecular study of eight additional cases of an emerging group of tyrosine kinase fusion mesenchymal tumours;Journal of Clinical Pathology;2024-06-04

5. Pan-Cancer Molecular Biomarkers;Clinics in Laboratory Medicine;2024-06